Reported about 6 hours ago
Abbott Laboratories (ABT) fell short of Q4 sales expectations, primarily due to challenges in its nutrition and diagnostics segments. However, the company's overall full-year forecast remained in line with predictions, buoyed by anticipated growth in medical device demand, which experienced double-digit sales increases in the quarter.
Source: YAHOO